Watne K, Hannisdal E, Nome O, Hager B, Hirschberg H
Department of Oncology, Norwegian Radium Hospital, Oslo.
Acta Oncol. 1993;32(3):307-10. doi: 10.3109/02841869309093600.
Survival was analyzed in 173 patients with malignant gliomas to study the importance of possible pretreatment prognostic factors. Seventy-nine of these patients received preirradiation intra-arterial chemotherapy with BCNU combined with vincristine intravenously and procarbazine orally; the others received only postoperative whole-brain irradiation. To judge by univariate and multivariate analyses the most important pretreatment prognostic factors were histology, corticosteroid dependency, pretreatment performance status and frontal lobe location of the tumors. Patients with anaplastic astrocytoma, not corticosteroid-dependent, with pretreatment performance status of 0-2 and with a frontal lobe location of the tumor seemed to benefit most from preirradiation chemotherapy.
对173例恶性胶质瘤患者的生存情况进行了分析,以研究可能的预处理预后因素的重要性。其中79例患者在放疗前接受了动脉内化疗,使用卡氮芥联合静脉注射长春新碱和口服丙卡巴肼;其余患者仅接受了术后全脑照射。通过单因素和多因素分析判断,最重要的预处理预后因素是组织学、皮质类固醇依赖性、预处理时的体能状态和肿瘤的额叶位置。间变性星形细胞瘤患者,不依赖皮质类固醇,预处理时体能状态为0 - 2且肿瘤位于额叶,似乎从放疗前化疗中获益最大。